Saxenda Weight Loss in Princeton NJ. FDA-Approved. Physician-Supervised.
Saxenda (Liraglutide) is an FDA-approved injectable GLP-1 medication for chronic weight management. At Sleep & Wellness Medical Associates in Princeton NJ, Saxenda is prescribed and monitored by Dr. Mahmood Siddique — quadruple board-certified physician with over 30 years of clinical experience.
- FDA-approved Liraglutide injection
- Physician-supervised program
- In-house lab work included
- InBody 970S body composition scanning
First GLP-1 approved for weight loss
In clinical trials with lifestyle changes
Princeton NJ physician-supervised care
5.0 rating · Sleep and Wellness
How Saxenda Works for Weight Loss
Saxenda is the brand name for Liraglutide — a GLP-1 receptor agonist approved by the FDA in 2014 specifically for chronic weight management in adults.
It works by mimicking the GLP-1 hormone released after eating. This signals the brain to reduce appetite, slows gastric emptying, and helps regulate blood sugar — creating the conditions for sustained weight loss when combined with a reduced-calorie diet and increased physical activity.
Saxenda is administered as a once-daily subcutaneous injection. The dose is gradually increased over five weeks to improve tolerability.
Mimics the natural GLP-1 hormone to reduce appetite and slow gastric emptying — creating a calorie deficit
Self-administered subcutaneous injection with a prefilled pen. Dose increases gradually over 5 weeks
One of the first GLP-1 medications specifically approved for chronic weight management in adults with obesity
Prescribed following in-house lab work and monitored with InBody 970S body composition scanning
Is Saxenda Right for You — or Is a Newer GLP-1 Better?
Saxenda was groundbreaking when approved in 2014. Since then, newer GLP-1 medications have been developed with significantly stronger clinical results.
Semaglutide (Wegovy) produces an average of 15% body weight reduction in clinical trials — compared to 5-8% with Saxenda. Tirzepatide (Zepbound, Mounjaro) produces up to 20% average weight reduction.
At Sleep and Wellness Medical Associates, Dr. Siddique evaluates each patient individually. For some patients — based on their health profile, medication history, insurance coverage and individual response — Saxenda remains the most appropriate choice. For others, a newer GLP-1 medication may be recommended.
The goal is not to prescribe a specific drug. The goal is to find the right medication for your specific situation.
Average weight reduction with Saxenda in clinical trials
FDA approval year — one of the original GLP-1 weight loss medications
Injection frequency — unlike weekly Semaglutide or Tirzepatide
Do You Qualify for Saxenda in Princeton NJ?
Saxenda is FDA-approved for adults who meet specific clinical criteria. A consultation with Dr. Siddique and in-house lab work are required before any prescription is written.
- BMI of 30 or higher OR
- BMI of 27 or higher with a weight-related health condition
- No personal or family history of medullary thyroid carcinoma
- Not currently pregnant
- Willing to combine medication with diet and lifestyle changes
Insurance Coverage
Dr. Mahmood Siddique, DO
GLP-1 medications like Saxenda require ongoing medical supervision — not just a prescription and a monthly shipment.
At Sleep and Wellness Medical Associates, Dr. Siddique monitors every Saxenda patient with in-house lab work and InBody 970S body composition scans. This allows him to track fat versus muscle loss, adjust dosage based on your response, and identify whether a different medication might produce better results.
The difference between Saxenda from a quadruple board-certified physician and Saxenda from a telehealth service is the level of medical oversight applied to your individual case.
- Quadruple Board-Certified — Internal Medicine, Pulmonary Disease, Critical Care and Sleep Medicine
- DO, FACP, FCCP, FAASM
- 30+ Years Active Clinical Practice in Princeton NJ
- GLP-1 Specialist — Saxenda, Semaglutide and Tirzepatide
Frequently Asked Questions
Saxenda is the brand name for Liraglutide — an FDA-approved once-daily injectable GLP-1 medication for chronic weight management in adults. It reduces appetite and slows gastric emptying to help create a sustained calorie deficit for weight loss.
Saxenda (Liraglutide) is injected daily and produces average weight loss of 5-8% in clinical trials. Wegovy (Semaglutide) is injected weekly and produces approximately 15% average weight loss. Mounjaro and Zepbound (Tirzepatide) produce up to 20%. Individual factors including insurance coverage, health history and medication tolerance influence which is most appropriate.
Coverage varies by insurance plan. We verify your benefits at no cost before your first visit so you know exactly what is covered.
Most patients see meaningful weight loss within 12 weeks with consistent use. The dose increases gradually over the first 5 weeks to improve tolerability.
Yes. We serve patients from across New Jersey. A consultation at our clinic is required before any prescription — Saxenda is not available through a telehealth-only process at our practice.
Yes. If your response to Saxenda is limited, Dr. Siddique can review your progress and discuss switching to a newer GLP-1 medication. All decisions are based on your lab work, InBody scan data and health profile.